Skip to main content
Back to RA Capital Management

RA Capital Management's Pharmaceutical Portfolio

Browse 21 Pharmaceutical companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
21
Total Funding in Pharmaceutical
$2.8B

Pharmaceutical Portfolio Companies (21)

Export
BiotechnologyHealth CarePharmaceuticalTherapeutics

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Durham, United States
April 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin, Ireland
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Wilmington, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Portland, United States
September 2025
$95.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
September 2025
$32.0M
Series A

Founder Contacts

19,000+ verified contacts

DeliveryMedicalPharmaceutical

Spyglass Pharma provides medicine for ophthalmic diseases.

Aliso Viejo, United States
June 2025
$75.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Boston, United States
April 2025
$59.2M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Seattle, United States
August 2024
$144.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
January 2026
$305.0M
Series F

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceutical

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

San Carlos, United States
January 2026
$1.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
December 2025
$402.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Boston, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Belite Bio is a clinical stage biopharmaceutical drug development company.

San Diego, United States
December 2025
$350.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Waltham, United States
November 2025
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio